| Literature DB >> 21512445 |
Shuang Guan1, Wei Wang, Jing Lu, Wenhui Qian, Guoren Huang, Xuming Deng, Xuelin Wang.
Abstract
Salidroside, a major component of Rhodiola rosea L., has shown various pharmacological functions, including antioxidant effects, but the signal transduction pathway of its antioxidant effects is not very clear. In this study, we found that salidroside could attenuate hydrogen peroxide (H(2)O(2))-induced HL-7702 cell damage, inhibit H(2)O(2)-induced cytosolic free Ca2+ ([Ca2+]i) elevation, scavenge reactive oxygen species (ROS) and increase 3'-5'-cyclic adenosine monophosphate (cAMP) level in a dose-dependent manner, but it couldn't influence 3'-5'-cyclic guanosine monophosphate (cGMP) levels. Therefore, these results indicated that the antioxidant effects of salidroside were associated with down-regulation of [Ca2+]i, ROS occur via a cAMP-dependent pathway.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21512445 PMCID: PMC6260613 DOI: 10.3390/molecules16043371
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structure of salidroside.
Figure 2Protective effect of salidroside on H2O2-induced cell damage. Cells were treated with salidroside followed by H2O2 as described in 2.2 and cell viability was determined by MTT assay.
Figure 3Salidroside inhibited H2O2-induced [Ca2+]i elevation (Recorded by inverted fluorescence microscope, Motic AE31 200×). (a). Control; (b). H2O2; (c). 0.03 μg/mL salidroside + H2O2; (d). 0.05 μg/mL salidroside + H2O2; (e). 0.1 μg/mL salidroside + H2O2; (f). Statistical analysis of fluorescence intensity data with Motic Advanced Images 3.2 software (China). Cells were treated with salidroside followed by H2O2 as described in 2.2. and [Ca2+]i levels were determined with Fluo-3/AM fluorescent dye.
Figure 4(a). Effect of salidroside on cAMP level in cells; (b). Effect of salidroside on cGMP level in cells. Cells were treated with salidroside followed by H2O2 as described in 2.2.Contents of cAMP and cGMP were measured using human cyclic adenosine monophosphate Elisa kits and human cyclic guanosine monophosphate Elisa kits respectively.
Figure 5Salidroside inhibited H2O2-induced ROS elevation (Recorded by inverted fluorescence microscope, Motic AE31 200×). (a). Control; (b). H2O2; (c). 0.03 μg/mL salidroside + H2O2; (d). 0.05 μg/mL salidroside + H2O2; (e). 0.1 μg/mL salidroside + H2O2; (f). Statistical analysis of fluorescence intensity data with Motic Advanced Images 3.2 software. Cells were treated with salidroside followed by H2O2 as described in 2.2.